Table 2.
DUBs in neurodegenerative diseases
| Disease | DUB | Interactor/substrate | Functional implications of the DUB | Reference |
|---|---|---|---|---|
| PD | USP8 | α-synuclein | Prevent lysosomal degradation of α-synuclein | [41] |
| PD | USP10 | P62 | Induce synaptic aggregates formation | [42] |
| PD | USP24 | ULK1 | Downregulate autophagic flux | [43] |
| PD | USP33 | Parkin | Inhibit mitophagy | [44] |
| AD | OTUB1 | Tau | Promote tau protein stability and aggregation | [45] |
| AD | USP46 | AMPARs | Regulate synaptic receptor levels | [46] |
| HD | ATXN3 | Beclin-1 | Regulate autophagy | [47] |
| ALS | USP7 | Nedd4L | Regulate SMAD-mediated protein quality control system | [48] |
Only the direct interactors/substrates for E3s and DUBS are listed. For each disease, the list is sorted alphabetically by “DUB”